Ethionamide
- Generic Name
- Ethionamide
- Brand Names
- Trecator
- Drug Type
- Small Molecule
- Chemical Formula
- C8H10N2S
- CAS Number
- 536-33-4
- Unique Ingredient Identifier
- OAY8ORS3CQ
Overview
A second-line antitubercular agent that inhibits mycolic acid synthesis. It also may be used for treatment of leprosy. (From Smith and Reynard, Textbook of Pharmacology, 1992, p868)
Background
A second-line antitubercular agent that inhibits mycolic acid synthesis. It also may be used for treatment of leprosy. (From Smith and Reynard, Textbook of Pharmacology, 1992, p868)
Indication
For use in the treatment of pulmonary and extrapulmonary tuberculosis when other antitubercular drugs have failed.
Associated Conditions
- Active Tuberculosis
Clinical Trials
FDA Approved Products
Trecator
Manufacturer:Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Route:ORAL
Strength:250 mg in 1 1
Approved: 2023/09/15
NDC:0008-4117
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath